Adela
PrivateLast Round
Seed Round
Apr 23, 2026
Total Funding Raised
$108M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Adela is a healthcare technology company that develops blood-based diagnostic tests for minimal residual disease monitoring and multi-cancer early detection using a genome-wide methylome enrichment platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adela Comparables
Compare Adela with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exai Bio | 86% | |
| Lucence | 85% | |
| Delfi Diagnostics | 84% | |
Adela Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 23, 2026 | ||||
| Seed Round | Feb 14, 2024 | ||||
| Seed Round | Feb 14, 2024 | ||||
| Series A Extension | Sep 25, 2023 | ||||
| Series A | Jun 23, 2021 |
Key People
Founding team and executive leadership
Adela Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series A Extension, Series A |
| RA Capital Management | Series A Extension, Series A |
| F-Prime Capital | Series A Extension, Series A |
| OrbiMed | Series A Extension, Series A |
| F-Prime Capital | Series A Extension, Series A |
| Decheng Capital | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
$5M round raised.
- Mar 26, 2026
Tissue-free liquid biopsy assay nearing commercialization for a new indication.
Adela Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adela's valuation, stock price, and market status.